Blog
RSS FeedPosted by Michael Wonder on 18 Dec 2016
Proposal to list a range of orthopaedic implants and associated products supplied by Zimmer Biomet New Zealand
16 December 2016 - PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated ...
Posted by Michael Wonder on 15 Dec 2016
Decision relating to anti-VEGF treatments for ophthalmic use
15 December 2016 - On 5 September 2016, PHARMAC consulted on a proposal to list ranibizumab (Lucentis) and aflibercept (Eylea) ...
Posted by Michael Wonder on 14 Dec 2016
Patients call for funding of drugs for rare disorders
13 December 2016 - People with rare health disorders are urging MPs to consider whether extra funding is needed for potentially ...
Posted by Michael Wonder on 14 Dec 2016
Somatropin for patients under 2 years with Prader-Willi Syndrome
14 December 2016 - PHARMAC is pleased to announce that somatropin (human growth hormone) will be fully funded for patients ...
Posted by Michael Wonder on 13 Dec 2016
Children of woman with rare disease ask Santa for 'mummy's medicine'
13 December 2016 - Two Kiwi children whose mother is fighting for life-saving treatment have asked Santa for "mummy's medicine" ...
Posted by Michael Wonder on 08 Dec 2016
Proposal to amend listings in the National Immunisation Schedule
9 December 2016 - Following a request for proposals for the supply of various vaccines, issued on 15 February 2016, ...
Posted by Michael Wonder on 08 Dec 2016
Decision regarding PHARMAC’s implementation of Trans-Pacific Partnership provisions and other amendments to application processes
8 December 2016 - PHARMAC is pleased to announce that changes will be made to its Operating Policies and Procedures ...
Posted by Michael Wonder on 06 Dec 2016
Heartless' to deny breast cancer drug
5 December 2016 - The Breast Cancer Foundation is demanding approval granted for a new drug be extended to those already ...
Posted by Michael Wonder on 06 Dec 2016
Clostridium botulinum type A toxin (Botox) in DHB hospitals
6 December 2016 - PHARMAC is seeking feedback on a proposal to amend the contractual terms of listing for clostridium botulinum ...
Posted by Michael Wonder on 05 Dec 2016
PHARMAC funds breast cancer drug Perjeta
5 December 2016 - More breast cancer sufferers will soon have access to a treatment programme that can extend lives ...
Posted by Michael Wonder on 04 Dec 2016
Approval of multi-product funding proposal with Roche
5 December 2016 - PHARMAC is pleased to announce a major funding package following an agreement with Roche for funding ...
Posted by Michael Wonder on 30 Nov 2016
New Zealand Pharmaceutical Schedule - 1 December 2016
1 December 2016 - The December 2016 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 24 Nov 2016
Petition to pressure PHARMAC over HIV meds
24 November 2016 - Three years after a irrefutable case was made by HIV organisations and specialists the NZAF is reporting ...
Posted by Michael Wonder on 16 Nov 2016
Proposal to list oral betaine for rare disorder
16 November 2016 - PHARMAC is seeking feedback on a proposal to list betaine (Cystadane) resulting from a provisional agreement ...
Posted by Michael Wonder on 14 Nov 2016
Decision to list enzyme replacement therapies for some rare disorders
11 November 2016 - PHARMAC is pleased to announce the approval of an agreement with Sanofi-Aventis for the listing of ...